GETI.B

202

+0.65%↑

CAMX

669

+0.22%↑

EKTA.B

47.08

-0.08%↓

VITR

129

+0.31%↑

AMBEA

132.4

+0.38%↑

GETI.B

202

+0.65%↑

CAMX

669

+0.22%↑

EKTA.B

47.08

-0.08%↓

VITR

129

+0.31%↑

AMBEA

132.4

+0.38%↑

GETI.B

202

+0.65%↑

CAMX

669

+0.22%↑

EKTA.B

47.08

-0.08%↓

VITR

129

+0.31%↑

AMBEA

132.4

+0.38%↑

GETI.B

202

+0.65%↑

CAMX

669

+0.22%↑

EKTA.B

47.08

-0.08%↓

VITR

129

+0.31%↑

AMBEA

132.4

+0.38%↑

GETI.B

202

+0.65%↑

CAMX

669

+0.22%↑

EKTA.B

47.08

-0.08%↓

VITR

129

+0.31%↑

AMBEA

132.4

+0.38%↑

Home・Elenco Azioni・BioArctic AB

B
BioArctic AB

Chiusa

284.6 -2.47

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

284.2

Massimo

285.2

Metriche Chiave
By Trading Economics
Entrata	-896M 179M
Vendite	-897M 392M
P/E Media del settore	23.701 35.69
EPS	1.09
Margine di Profitto	45.668
Dipendenti	119
EBITDA	-893M 188M

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	4.5B 25B
Apertura precedente	287.07
Chiusura precedente	284.6

BioArctic AB Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

26 set 2025, 18:25 UTC

I principali Market Mover

Mirion Technologies Stock Rises on Expanded Notes, Shares Offerings

27 set 2025, 07:00 UTC

Utili

This Water Stock Is Dehydrated. What Could Bring It Back. -- Barrons.com

27 set 2025, 04:15 UTC

Discorsi di Mercato

Global Commodities Roundup: Market Talk

26 set 2025, 21:56 UTC

Acquisizioni, Fusioni, Takeovers

Staar Surgical, Insight Enterprises, and More Stocks See Action From Activist Investors -- Barrons.com

26 set 2025, 20:54 UTC

Utili

U.S. TikTok for $14 Billion? Making Sense of the Bargain-Basement Price. -- Barrons.com

26 set 2025, 20:50 UTC

Discorsi di Mercato

Tech, Media & Telecom Roundup: Market Talk

26 set 2025, 20:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

26 set 2025, 20:27 UTC

Acquisizioni, Fusioni, Takeovers

Electronic Arts Stock Pops on Report Videogame Maker Is Close to Going Private -- Barrons.com

26 set 2025, 20:15 UTC

Discorsi di Mercato

Global Commodities Roundup: Market Talk

26 set 2025, 19:54 UTC

Discorsi di Mercato

Canada's Can't-Build Reputation Is Somewhat Earned -- Market Talk

26 set 2025, 19:53 UTC

Acquisizioni, Fusioni, Takeovers

Electronic Arts Stock Pops on Report Videogame Maker Is Close to Going Private -- Barrons.com

26 set 2025, 19:40 UTC

Utili

The U.S. TikTok Is Apparently Fetching a Bargain-Basement Price. A Few Reasons Why. -- Barrons.com

26 set 2025, 19:24 UTC

Discorsi di Mercato

U.S. Natural Gas Futures Mixed As October Expires -- Market Talk

26 set 2025, 19:17 UTC

Discorsi di Mercato

Oil Posts Weekly Gains on Russia-Ukraine Tensions -- Market Talk

26 set 2025, 19:15 UTC

Discorsi di Mercato

AI Deployment Beginning to Weigh on Job Creation, Former Central Banker Says -- Market Talk

26 set 2025, 19:03 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

26 set 2025, 19:03 UTC

Discorsi di Mercato

Gold Fuels Stellar Performance in Toronto Stock Market -- Market Talk

26 set 2025, 18:50 UTC

Discorsi di Mercato

Utili

Costco's Executive Membership Gains Seen as Offsetting Slower Renewal Rates -- Market Talk

26 set 2025, 18:36 UTC

Discorsi di Mercato

Silver Closes Out Week With Strong Surge -- Market Talk

26 set 2025, 18:02 UTC

Acquisizioni, Fusioni, Takeovers

ING: Continue Working Towards Completing Transaction, Exit From Russian Market >ING

26 set 2025, 18:02 UTC

Acquisizioni, Fusioni, Takeovers

ING: Global Development Hasn't Received All Necessary Approvals >ING

26 set 2025, 18:02 UTC

Acquisizioni, Fusioni, Takeovers

ING: No Realistic Prospect of Completing Sale of ING Bank (Eurasia) to Global Development in 3Q

26 set 2025, 17:54 UTC

Discorsi di Mercato

U.S. Oil Rig Count Rises For Fifth Straight Week -- Market Talk

26 set 2025, 16:56 UTC

Discorsi di Mercato

Utili

Costco Increasingly Challenged to Meet Lofty Expectations -- Market Talk

26 set 2025, 16:41 UTC

Discorsi di Mercato

Utili

Costco's Valuation Seen as Too High Amid Slow Down -- Market Talk

26 set 2025, 16:26 UTC

Utili

Correction to Sherwin-Williams Extends Losses. What's Ailing the Paint Maker. -- Barrons.com

26 set 2025, 16:20 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

26 set 2025, 16:12 UTC

Discorsi di Mercato

Nike Stock Seen With Limited Upside -- Market Talk

26 set 2025, 15:59 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

26 set 2025, 15:59 UTC

Discorsi di Mercato

Nike Seen Showing Progress in Turnaround -- Market Talk

Confronto tra pari

Modifica del prezzo

BioArctic AB Previsione

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo BioArctic AB

BioArctic AB (publ) develops biological drugs for patients with disorders of the central nervous system in Sweden. The company develops Lecanemab, Lecanemab AHEAD 3-45, and Lecanemab Back-up for the treatment of Alzheimer's disease. In addition, the company develops AD-BT2802 and AD-BT2803 drug projects against Alzheimer's disease that are being combined with blood-brain barrier technology and Brain Transporter to promote uptake of antibodies into the brain. Further, it develops BAN1503, BAN2802, BAN2803, and AD2603 for the treatment of Alzheimer's disease; ND-BT3814, ND3014, andGD-BT6822 for the treatment of neurodegenerative disease; and PD1601, PD-BT2238, and PD1602 for the treatment of Parkinson's disease. It has research collaboration agreement with Eisai and AbbVie. The company was formerly known as BioArctic Neuroscience AB and changed its name to BioArctic AB (publ) in 2016. BioArctic AB (publ) was incorporated in 2000 and is based in Stockholm, Sweden.